| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.2 |